Placental protein 13 (PP13)-induced vasodilation of resistance arteries from pregnant and nonpregnant rats occurs via endothelial-signaling pathways

Hypertens Pregnancy. 2017 May;36(2):186-195. doi: 10.1080/10641955.2017.1295052. Epub 2017 May 19.

Abstract

Placental protein 13 (PP13) induces hypotension in rats. This study aims to evaluate PP13 effects on isolated uterine arteries from nonpregnant and mid-pregnant rats. Vessels were isolated, cannulated, and pressurized to 50 mmHg within an arteriograph, preconstricted and exposed to increasing PP13 concentrations (10-13-10-8 M). PP13 elicited 38-50% arterial vasodilation with half-maximum response (EC50) = 1 pM. The relaxation was mediated by activating the endothelial-signaling pathways of prostaglandin and nitric oxide (NO). Accordingly, these results encourage evaluation of PP13 as a possible therapy for gestational diseases characterized by insufficient uteroplacental blood flow and/or maternal hypertension.

Keywords: eNOS; endothelial layers; preeclampsia; prostacyclin (PGI2); uterine vasculature.

MeSH terms

  • Animals
  • Benzyl Compounds
  • Calcium / metabolism
  • Cyclooxygenase 1 / metabolism
  • Cyclooxygenase 2 / metabolism
  • Endothelium, Vascular / metabolism*
  • Female
  • Galectins / physiology*
  • Imidazoles
  • Membrane Proteins / metabolism
  • Nitric Oxide Synthase / metabolism
  • Pregnancy
  • Pregnancy Proteins / physiology*
  • Pregnancy, Animal / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Uterine Artery / physiology*
  • Vasodilation*

Substances

  • (2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)
  • Benzyl Compounds
  • Galectins
  • Imidazoles
  • Membrane Proteins
  • Pregnancy Proteins
  • placental protein 13, rat
  • Nitric Oxide Synthase
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Ptgs1 protein, rat
  • Ptgs2 protein, rat
  • Calcium